COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia

References

• Poukka E, Nohynek H, Goebeler S, Leino T, UJm B. Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022–March 2023. medRxiv. 2023;2023.03. 02.23286561.
   Google Scholar
• Nehal KR, Steendam LM, Campos Ponce M, van der Hoeven M, Smit GSA. Worldwide vaccination willingness for COVID-19: a systematic review and meta-analysis. Vaccines. 2021;9(10):1071. doi: 10.3390/vaccines9101071.
   Web of Science ®Google Scholar
• Hacker KA, Briss PA, Richardson L, Wright J, Petersen R. Peer reviewed: COVID-19 and chronic disease: the impact now and in the future. Prev Chronic Dis. 2021;18. doi: 10.5888/pcd18.210086.
   Web of Science ®Google Scholar
• Montarello NL, Wong HZ, Jeffries A, Perkins GB, Hissaria P, Stokes MB, Raith E, Teo K, Bradley J. Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: a case study. Crit Care Resusc. 2023;25(3):155–20. doi: 10.1016/j.ccrj.2023.06.005.
   PubMed Web of Science ®Google Scholar
• Hussain A, Bhowmik B, Do Vale Moreira NC. COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142. doi: 10.1016/j.diabres.2020.108142.
   PubMed Web of Science ®Google Scholar
• Noor FM, MMJJoch I. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health. 2020;45(6):1270–1282. doi: 10.1007/s10900-020-00920-x.
   PubMed Web of Science ®Google Scholar
• Toubasi AA, RB A, Tawileh HBA, Aldebei RH, SASJPR A. A meta-analysis: the mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Res. 2021;299:113856. doi: 10.1016/j.psychres.2021.113856.
   PubMed Web of Science ®Google Scholar
• Driggin E, Maddox TM, Ferdinand KC, Kirkpatrick JN, Ky B, Morris AA, Mullen JB, Parikh SA, Philbin DM, Vaduganathan M, et al. ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization. J Am Coll Cardiol. 2021;77(15):1938–1948. doi: 10.1016/j.jacc.2021.02.017.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, Bonanomi E, Cabrini L, Carlesso E, Castelli G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Internal Medicine. 2020;180(10):1345–1355. doi: 10.1001/jamainternmed.2020.3539.
   PubMed Web of Science ®Google Scholar
• Atkins JL, Masoli JA, Delgado J, Pilling LC, Kuo C-L, Kuchel GA, Melzer D. Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontology: Series A. 2020;75(11):2224–2230. doi:10.1093/gerona/glaa183.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5). doi: 10.1183/13993003.01227-2020.
   Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Factors associated with COVID-19-related death using Open SAFELY. Nature. 2020;584(7821):430–436. doi: 10.1038/s41586-020-2521-4.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, Wei J, Gong Z, Zhou C, Yu H, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infec. 2020;26(6):767–772. doi: 10.1016/j.cmi.2020.04.012.
   PubMed Web of Science ®Google Scholar
• Hong Nguyen N T, T-Y O, Huy LD, Shih C-L, Chang Y-M, Phan T-P, Huang C-C. A global analysis of COVID-19 infection fatality rate and its associated factors during the delta and omicron variant periods: an ecological study. Front Public Health. 2023;11:1145138. doi: 10.3389/fpubh.2023.1145138.
   PubMed Web of Science ®Google Scholar
• World Health Organization. COVID-19 epidemiological update. 162th ed. Switzerland, Geneva: WHO; 2023. p. 26.
   Google Scholar
• Palmieri L, Floridia M, Giuliano M, Tiple D, Noce CL, Meli P, Onder G. Clinical characteristics of SARS-CoV-2 fully-vaccinated patients dying with COVID-19 in Italy. Clin Microbiol Infect. 2022;28(6):890–892. doi: 10.1016/j.cmi.2022.01.024.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yuan W, Zhan H, Kang H, Li X, Chen Y, Li H, Sun X, Cheng L, Zheng H, et al. SARS-CoV-2 vaccine uptake among patients with chronic liver disease: a cross-sectional analysis in Hebei Province, China. Vaccines. 2023;11(8):1293. doi: 10.3390/vaccines11081293.
   Web of Science ®Google Scholar
• Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817. doi: 10.3389/fimmu.2020.01817.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Du J, Li Z, Xu Z, Wu Y, Duan W, Wang W, Zhang T, Xu J, Wu H, et al. It is time to improve the acceptance of COVID-19 vaccines among people with chronic diseases: a systematic review and meta-analysis. J Med Virol. 2023;95(2):e28509. doi: 10.1002/jmv.28509.
   PubMed Web of Science ®Google Scholar
• Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen IM, James W, Gordon S, Pepper MS. SARS-CoV-2 variants, vaccines, and host immunity. Front Immunol. 2022;12:809244. doi: 10.3389/fimmu.2021.809244.
   PubMed Web of Science ®Google Scholar
• Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20(8):921–933. doi: 10.1080/14760584.2021.1949291.
   PubMed Web of Science ®Google Scholar
• Eneh SC, Okonji OC, Chiburoma AG, Francisca Ogochukwu O, Tuwleh L, Gideon I, Okonji EF, Bushabu FN, Mgbere O. Marburg virus disease amid COVID-19 in West Africa: an emerging and re-emerging zoonotic epidemic threat, future implications and way forward. Ther Adv Infect Dis. 2023;10. doi: 10.1177/20499361231168520.
   PubMed Web of Science ®Google Scholar
• Belay GM, Alemu TG, Techane MA, Wubneh CA, Assimamaw NT, Tamir TT, Muhye AB, Kassie DG, Wondim A, Terefe B, et al. COVID-19 vaccine acceptance rate and its predictors in Ethiopia: a systematic review and meta-analysis. Hum Vaccines Immunother. 2022;18(6):2114699. doi: 10.1080/21645515.2022.2114699.
   PubMed Web of Science ®Google Scholar
• Berihun G, Walle Z, Berhanu L, Teshome D. Acceptance of COVID-19 vaccine and determinant factors among patients with chronic disease visiting Dessie comprehensive specialized Hospital, Northeastern Ethiopia. Patient Prefer Adherence. 2021;15:1795–1805. doi: 10.2147/PPA.S324564.
   PubMed Web of Science ®Google Scholar
• Gudayu TW, Mengistie HT. COVID-19 vaccine acceptance in sub-Saharan African countries: a systematic review and meta-analysis. Heliyon. 2023;9(2):e13037. doi: 10.1016/j.heliyon.2023.e13037.
   PubMed Web of Science ®Google Scholar
• Melak K. Magnitude of covid-19 vaccine acceptance and associated factors among patients with chronic disease at wachamo university nigist eline Mohammed comprehensive specialized hospital. Southern Ethiopia: HU; 2022.
   Google Scholar
• Mengistu DA, Demmu YM, Asefa YAJFi PH. Global COVID-19 vaccine acceptance rate: systematic review an meta-analysis. Front Public Health. 2022;10:1044193. doi: 10.3389/fpubh.2022.1044193.
   PubMedGoogle Scholar
• Mesele H, Shiferaw M, Tunta A, Seid A, Kassahun W. Willingness to receive COVID-19 vaccination among adult diabetes patients in woldia comprehensive specialized hospital, North Ethiopia; a cross-sectional study. Patient Prefer Adherence. 2022;Volume 16:2451–2459. doi: 10.2147/PPA.S379531.
   Web of Science ®Google Scholar
• Mesfin Y, Argaw M, Geze S, Zewdu BT. Factors associated with intention to receive COVID-19 vaccine among HIV positive patients attending ART clinic in Southwest Ethiopia. Patient Prefer Adherence. 2021;15:2731–2738. doi: 10.2147/PPA.S342801.
   PubMed Web of Science ®Google Scholar
• Mose A, Wasie A, Shitu S, Haile K, Timerga A, Melis T, Sahle T, Zewdie A. Determinants of COVID-19 vaccine acceptance in Ethiopia: a systematic review and meta-analysis. PLoS One. 2022;17(6):e0269273. doi: 10.1371/journal.pone.0269273.
   PubMed Web of Science ®Google Scholar
• Adeagbo M, Olukotun M, Musa S, Alaazi D, Allen U, Renzaho AMN, Sekyi-Otu A, Salami B. Improving COVID-19 vaccine uptake among black populations: a systematic review of strategies. Int J Environ Res Public Health. 2022;19(19):11971. doi: 10.3390/ijerph191911971.
   PubMed Web of Science ®Google Scholar
• Adu P, Poopola T, Medvedev ON, Collings S, Mbinta J, Aspin C, Simpson CR. Implications for COVID-19 vaccine uptake: a systematic review. J Infect Public Health. 2023;16(3):441–466. doi: 10.1016/j.jiph.2023.01.020.
   PubMed Web of Science ®Google Scholar
• Dada D, Djiometio JN, McFadden SM, Demeke J, Vlahov D, Wilton L, Wang M, Nelson LE. Strategies that promote equity in COVID-19 vaccine uptake for black communities: a review. J Urban Health. 2022;99(1):15–27. doi: 10.1007/s11524-021-00594-3.
   PubMed Web of Science ®Google Scholar
• Fernández-Sánchez H, Zahoui Z, Jones J, Marfo EA, Dinga JN. Access, acceptability, and uptake of the COVID-19 vaccine among global migrants: a rapid review. PLoS One. 2023;18(6):e0287884. doi: 10.1371/journal.pone.0287884.
   PubMed Web of Science ®Google Scholar
• Viswanath K, Bekalu M, Dhawan D, Pinnamaneni R, Lang J, McLoud R. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health. 2021;21(1):818. doi: 10.1186/s12889-021-10862-1.
   PubMed Web of Science ®Google Scholar
• Fekete M, Horvath A, Santa B, Tomisa G, Szollosi G, Ungvari Z, Fazekas-Pongor V, Major D, Tarantini S, Varga JT, et al. COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease–A cross-sectional study in Hungary. Vaccine. 2023;41(1):193–200. doi: 10.1016/j.vaccine.2022.11.020.
   PubMed Web of Science ®Google Scholar
• Abate BB, Tilahun BD, Yayeh BM. Global COVID-19 vaccine acceptance level and its determinants: an umbrella review. BMC Public Health. 2024;24(1):5.
   PubMed Web of Science ®Google Scholar
• Mekonnen BD, Mengistu BA. COVID-19 vaccine acceptance and its associated factors in Ethiopia: a systematic review and meta-analysis. Clin Epidemiol Glob Health. 2022;14:101001. doi: 10.1016/j.cegh.2022.101001.
   PubMed Web of Science ®Google Scholar
• Worede DT, Kassahun M, Endalew B. COVID-19 vaccine acceptance and predictors among pregnant women in Ethiopia: systematic review and meta-analysis. Public Health Pract (Oxf). 2023;5:100386. doi: 10.1016/j.puhip.2023.100386.
   PubMedGoogle Scholar
• Daba C, Asefa L, Lemma H, Atamo A, Kebede E, Gebrehiwot M. Why does COVID-19 vaccine acceptance rate remain low among patients with chronic diseases? Evidences from public hospitals of Ethiopia. Patient Prefer Adherence. 2022;Volume 16:1371–1380. doi: 10.2147/PPA.S362131.
   Web of Science ®Google Scholar
• Dagnew Baye N, Agegnehu Teshome A, Agimas Ayenew A, Tilahun Mulu A, Chekol Abebe E, Tilahun Muche Z, Tu W-J. Attitude and level of COVID-19 vaccination and its determinants among patients with chronic disease visiting Debre Tabor comprehensive specialized hospital, Northwest Ethiopia: a cross-sectional study. PLoS One. 2022;17(12):e0278914. doi: 10.1371/journal.pone.0278914.
   PubMed Web of Science ®Google Scholar
• Parums DV. Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monitor: Intern Medi J Experimental Clin Res. 2021;27:e934475–1. doi: 10.12659/MSM.934475.
   Google Scholar
• Abetu Mehari E, Mekonen TG, Tesfahun Adugnaw M, Abubeker Abdela OJAi PH. Prevalence of COVID-19 vaccine hesitancy and its associated factors among chronic disease patients in a resource limited setting in Ethiopia: a cross-sectional study. Adv Public Health. 2023;2023:1–11. doi: 10.1155/2023/1776205.
   Google Scholar
• Adella GA, Abebe K, Atnafu N, Azeze GA, Alene T, Molla S, Ambaw G, Amera T, Yosef A, Eshetu K, et al. Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: multi-center study. Front Public Health. 2022;10:917925. doi: 10.3389/fpubh.2022.917925.
   PubMed Web of Science ®Google Scholar
• Kebede M, Biresaw H, Andargie A, Ewunetu M, Tegegne D, Dessie G. Corona virus disease-19 vaccine uptake, willingness for vaccination and associated factors among patients attending chronic follow up in the referral hospitals Bahir Dar, Ethiopia, 2022: a hospital based cross-sectional study. 2022.
   Google Scholar
• Mekonnen CK, Demissie NG, Beko ZW, Ferede YM, HKJIjoAns A. Intent to get vaccinated against COVID-19 pandemic and its associated factors among adults with a chronic medical condition. Int J Afr Nurs Sci. 2022;16:100401. doi: 10.1016/j.ijans.2022.100401.
   PubMedGoogle Scholar
• Tadele Admasu F. Knowledge and proportion of COVID-19 vaccination and associated factors among cancer patients attending public hospitals of Addis Ababa, Ethiopia, 2021: a multicenter study. Infect Drug Resist. 2021;Volume 14:4865–4876. doi: 10.2147/IDR.S340324.
   Web of Science ®Google Scholar
• Tegegne MD, Girma S, Mengistu S, Mesfin T, Adugna T, Kokeb M, Melese EB, Worku YB, Wubante SM. Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia. PLoS One. 2022;17(7):e0269942. doi: 10.1371/journal.pone.0269942.
   PubMed Web of Science ®Google Scholar
• Joanna Briggs Institute. Critical appraisal checklist for systematic reviews and research syntheses. 2020.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101. doi: 10.2307/2533446.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• McShane BB, Böckenholt U, Hansen KT. Adjusting for publication bias in meta-analysis: an evaluation of selection methods and some cautionary notes. Respect Psychol Sci. 2016;11(5):730–749. doi: 10.1177/1745691616662243.
   Web of Science ®Google Scholar
• Page MJ, Sterne JA, Higgins JP, Egger M. Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: a review. Res Synth Methods. 2021;12(2):248–259. doi: 10.1002/jrsm.1468.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. A nonparametric“trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95(449):89–98. doi: 10.1080/01621459.2000.10473905.
   Web of Science ®Google Scholar
• Favorito LA. Systematic review and metanalysis in urology: how to interpret the forest plot. Int Braz J Urol. 2023;49(6):775–778. doi: 10.1590/s1677-5538.ibju.2023.9911.
   PubMed Web of Science ®Google Scholar
• van den Heuvel ER, Almalik O, ZJae-P Z. Simulation models for aggregated data meta-analysis: evaluation of pooling effect sizes and publication biases. arXiv E-Prints. 2020;arXiv: 2009.06305.
   Google Scholar
• Mathur MB, VanderWeele TJ. Sensitivity analysis for publication bias in meta-analyses. J R Stat Soc Ser C Appl Stat. 2020;69(5):1091–1119. doi: 10.1111/rssc.12440.
   PubMed Web of Science ®Google Scholar
• Alemayehu A, Demissie A, Yusuf M, Gemechu Lencha A, Oljira L. Covid-19 vaccine acceptance and determinant factors among general public in East Africa: a systematic review and meta-analysis. Health Serv Res Manag Epidemiol. 2022;9:23333928221106269. doi: 10.1177/23333928221106269.
   Web of Science ®Google Scholar